SBI Term Loan: RLLR: 8.15 | 7.25% - 8.55%
Canara Bank: RLLR: 8 | 7.15% - 9.85%
ICICI Bank: RLLR: -- | 8.5% - 9.65%
Punjab & Sind Bank: RLLR: 7.3 | 7.35% - 10.75%
Bank of Baroda: RLLR: 7.9 | 7.2% - 8.95%
Federal Bank: RLLR: -- | 7.35% - 9.6%
IndusInd Bank: RLLR: -- | 7.6% - 10%
Bank of Maharashtra: RLLR: 8.05 | 7% - 9.15%
Yes Bank: RLLR: -- | 7.4% - 10.54%
Karur Vysya Bank: RLLR: 8.8 | 8.5% - 10.65%
HDFC Bank: RLLR: -- | 7.75% - 13.2%
Axis Bank: RLLR: -- | 8% - 9.1%
IDBI Bank: RLLR: -- | 7.4% - 10%

Sahajanand Medical Technologies raises INR 140 crore from anchor investors ahead of IPO

#Taxation & Finance News#Commercial#India
Synopsis

Cardiac stent maker Sahajanand Medical Technologies has raised INR 140 crore from anchor investors a day before its INR 475 crore IPO opens. The issue, from October 15 to 19, is entirely an offer for sale of up to 1.38 crore shares, so the company will not receive any proceeds. Shares were allotted to anchors at INR 344, the top of the INR 327 to INR 344 band. Offer documents show the company reported revenue of about INR 1,210 crore for 2025-26, and shares are proposed to be listed on October 23.

Sahajanand Medical Technologies Ltd, a manufacturer of cardiac stents, on Wednesday raised INR 140 crore from anchor investors ahead of its INR 475 crore IPO, which will open for public subscription on Thursday. The company allotted 40.71 lakh equity shares to anchor investors at INR 344 apiece, the upper end of the IPO price band, according to a circular uploaded on stock exchanges. Some of the investors that participated in the anchor book included Allianz Global Investors Fund, Natixis International Funds (Lux) I, Tata AIA Life Insurance Company, DSP Mutual Fund, Nippon India Mutual Fund and WhiteOak Capital Mutual Fund. The initial public offering will open for subscription on October 15 and close on October 19, and the price band has been fixed at INR 327 to INR 344 per share. 
The public issue is entirely an offer for sale (OFS) of up to 1.38 crore equity shares by existing shareholders, with no fresh issue component. Consequently, the company will not receive any proceeds from the IPO. According to the offer documents, the sellers are the promoter Shree Hari Trust, promoter group member Dhirajkumar Savjibhai Vasoya and investor shareholders Samara Capital, Kotak Pre-IPO Opportunities Fund and NHPEA Sparkle Holding B.V. Not more than 50 per cent of the net offer is reserved for qualified institutional buyers, not less than 15 per cent for non-institutional bidders and not less than 35 per cent for retail investors. The company's shares are proposed to be listed on the BSE and NSE on October 23. 
Founded in 2001, Sahajanand Medical Technologies develops, manufactures and sells medical devices used in vascular and structural heart interventions. Its products include coronary stents, balloons, transcatheter aortic valve implantation devices, occluders, renal stents and peripheral drug-coated balloons. According to the offer documents reported by market data providers, the company generated revenue from 77 countries in 2025-26, and its drug-eluting stents held nearly 25 per cent of India's volume in that year. Its three plants make the devices, and the company is headquartered in Mumbai, with its registered office in Surat, Gujarat. Motilal Oswal Investment Advisors, Avendus Capital, HSBC Securities and Capital Markets (India) and Nuvama Wealth Management are the book-running lead managers. 
On financials, the offer documents show revenue from operations of about INR 1,210.5 crore for 2025-26, up 18.1 per cent from INR 1,024.9 crore a year earlier, and a profit after tax of INR 69.08 crore against INR 25.15 crore. For the quarter ended June 2026, the company reported revenue of about INR 351.6 crore and a profit of INR 15.1 crore. The IPO is one of several opening this week, alongside the INR 5,012 crore issue from Zetwerk, which also opens on October 15, and comes as Paramotor Digital Technology filed updated draft papers for its own INR 1,000 crore offering. Because it is a pure offer for sale, proceeds go to the selling shareholders. 
Source PTI

Discussion

Have something to say? Post your comment